Skip to main content
TipRanks
Go Ultimate75% OFF

Plc Astrazeneca Insider Profile

11 Followers

Plc Astrazeneca, former Ten Percent Owner at Regulus, holds 0.00 shares in Viela Bio (Ticker: VIE), holds 3.00M shares in Phasebio Pharmaceuticals (Ticker: PHASQ), holds 2.16M shares in Entasis Therapeutics Holdings (Ticker: ETTX).

Plc Astrazeneca's Trading History

VIE
Viela Bio
Mar 16, 2021―Uninformative Sell776.47M$0.00
PHASQ
Phasebio Pharmaceuticals
Oct 24, 2018―Uninformative Buy13.67K$72.11K
ETTX
Entasis Therapeutics Holdings
Oct 02, 2018―Uninformative Buy―$4.74M
ALBO
Albireo Pharma
Dec 05, 2017―Informative Sell10.70M$22.43M
RGLS
Regulus
Nov 14, 2014―Informative Sell34.00M$34.68M

You May Also Like

Plc Astrazeneca insider profile FAQ

What is the percentage of profitable transactions made by Plc Astrazeneca?
The percentage of profitable transactions made by Plc Astrazeneca is 50%.
What is the average return per transaction made by Plc Astrazeneca?
The average return per transaction made by Plc Astrazeneca is 16.40%.
What stocks does Plc Astrazeneca hold?
Plc Astrazeneca holds: RGLS, ALBO, ETTX, PHASQ, VIE stocks.
What was Plc Astrazeneca’s latest transaction?
Plc Astrazeneca’s latest transaction was an Uninformative Sell of $776.47M.
What was Plc Astrazeneca's most profitable transaction?
Plc Astrazeneca’s most profitable transaction was an Informative Buy of VIE stock on October 9, 2019. The return on the trade was 63.70%.
What is Plc Astrazeneca's role in Regulus?
Plc Astrazeneca's role in Regulus is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.